From The Daily: Medical researchers from 扒哥黑料, New York University (NYU), and University Hospitals have been awarded a five-year, $3 million National Cancer Institute grant to develop and apply artificial intelligence (AI) tools for predicting which lung cancer patients will respond to immunotherapy.
For the first time, the study will involve testing the team's specific AI tools during an ongoing clinical trial. While these real-time treatment predictions will be used exclusively for research鈥揳nd not for clinical diagnosis or treatment鈥搕he work is the next step toward trials that would allow physicians to apply the tools with participating patients.
鈥淐linical trials down the road will be our biggest test, but now we will be鈥攆or the first time鈥攕tudying changes in the tissue-scan patterns of patients as they are being treated, and that will provide real-world context of our tools,鈥 said Anant Madabhushi, PhD director of Case Western Reserve鈥檚 Center for Computational Imaging and Personalized Medicine. 鈥淥ur AI tools have excelled in previous studies, but they have all been after-the-fact.鈥 Dr. Madabhushi, the Donnell Institute Professor of Biomedical Engineering at Case School of Engineering, is a member of the Case Comprehensive Cancer Center's Cancer Imaging Program.